Antitumor Vorinostat Purity Vorinostat Powder Vorinostat

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of US$ 30/kg
Request Sample
Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Management System Certification
ISO 9001, ISO 14001, GMP, HACCP
  • Antitumor Vorinostat Purity Vorinostat Powder Vorinostat
  • Antitumor Vorinostat Purity Vorinostat Powder Vorinostat
  • Antitumor Vorinostat Purity Vorinostat Powder Vorinostat
  • Antitumor Vorinostat Purity Vorinostat Powder Vorinostat
  • Antitumor Vorinostat Purity Vorinostat Powder Vorinostat
  • Antitumor Vorinostat Purity Vorinostat Powder Vorinostat
Find Similar Products
  • Overview
  • Product Description
  • Product Details
  • Application&Function
  • Specification
Overview

Basic Info.

Model NO.
D-sung Vorinostat
Suitable for
Elderly, Adult
State
Powder
Purity
>99%
Product Name
Vorinostat
Name
Vorinostat Powder
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Pharmaceutical
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
149647-78-9
Mf
C14h20n2o3
MW
264.32
Melting Point
161-162 C
Density
1.2
Transport Package
Negotiable
Specification
99%
Trademark
D-sung
Origin
Shaanxi Xi′an
Production Capacity
1000kg/Month

Product Description

Antitumor Vorinostat Purity Vorinostat Powder Vorinostat
Antitumor Vorinostat Purity Vorinostat Powder Vorinostat
Product Description
Antitumor Vorinostat Purity Vorinostat Powder VorinostatAntitumor Vorinostat Purity Vorinostat Powder Vorinostat
Product Details
Antitumor Vorinostat Purity Vorinostat Powder Vorinostat
Product name Vorinostat
Appearance White powder
CAS NO. 149647-78-9
MF C14H20N2O3
MW 264.3202
Vorinostat can play a role by inducing cell differentiation, blocking the cell cycle, and inducing cell regulation. Treatment of aggravation, persistence, and recurrence or ineffective cutaneous T-cell lymphoma (CTCL, a non-Hodgkin's lymphoma) after treatment with two systemic drugs. CTCL is a type of T cell carcinoma that affects the white blood cell types of the skin.
Application&Function
Antitumor Vorinostat Purity Vorinostat Powder Vorinostat

For the treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma who have progressive, persistent or recurrent disease on or following two systemic therapies; treatment of CTCL;treating acute myeloid leukemia.

Specification
Antitumor Vorinostat Purity Vorinostat Powder VorinostatAntitumor Vorinostat Purity Vorinostat Powder VorinostatAntitumor Vorinostat Purity Vorinostat Powder Vorinostat
Antitumor Vorinostat Purity Vorinostat Powder VorinostatAntitumor Vorinostat Purity Vorinostat Powder VorinostatAntitumor Vorinostat Purity Vorinostat Powder Vorinostat
Antitumor Vorinostat Purity Vorinostat Powder Vorinostat
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier